These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 25900135)

  • 1. Influenza B virus-specific CD8+ T-lymphocytes strongly cross-react with viruses of the opposing influenza B lineage.
    van de Sandt CE; Dou Y; Vogelzang-van Trierum SE; Westgeest KB; Pronk MR; Osterhaus ADME; Fouchier RAM; Rimmelzwaan GF; Hillaire MLB
    J Gen Virol; 2015 Aug; 96(8):2061-2073. PubMed ID: 25900135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human cytotoxic T lymphocytes directed to seasonal influenza A viruses cross-react with the newly emerging H7N9 virus.
    van de Sandt CE; Kreijtz JH; de Mutsert G; Geelhoed-Mieras MM; Hillaire ML; Vogelzang-van Trierum SE; Osterhaus AD; Fouchier RA; Rimmelzwaan GF
    J Virol; 2014 Feb; 88(3):1684-93. PubMed ID: 24257602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation at Extra-epitopic Amino Acid Residues Influences Suppression of Influenza Virus Replication by M1
    van de Sandt CE; Pronk MR; van Baalen CA; Fouchier RAM; Rimmelzwaan GF
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29593036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A human CD4+ T cell epitope in the influenza hemagglutinin is cross-reactive to influenza A virus subtypes and to influenza B virus.
    Babon JA; Cruz J; Ennis FA; Yin L; Terajima M
    J Virol; 2012 Sep; 86(17):9233-43. PubMed ID: 22718815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Role of Influenza Virus Exposure History in Determining Pandemic Susceptibility and CD8+ T Cell Responses.
    Quiñones-Parra SM; Clemens EB; Wang Z; Croom HA; Kedzierski L; McVernon J; Vijaykrishna D; Kedzierska K
    J Virol; 2016 Aug; 90(15):6936-6947. PubMed ID: 27226365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant impact of sequence variations in the nucleoprotein on CD8 T cell-mediated cross-protection against influenza A virus infections.
    Zhong W; Liu F; Dong L; Lu X; Hancock K; Reinherz EL; Katz JM; Sambhara S
    PLoS One; 2010 May; 5(5):e10583. PubMed ID: 20485501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human T-cells directed to seasonal influenza A virus cross-react with 2009 pandemic influenza A (H1N1) and swine-origin triple-reassortant H3N2 influenza viruses.
    Hillaire MLB; Vogelzang-van Trierum SE; Kreijtz JHCM; de Mutsert G; Fouchier RAM; Osterhaus ADME; Rimmelzwaan GF
    J Gen Virol; 2013 Mar; 94(Pt 3):583-592. PubMed ID: 23152369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virus-specific T cells as correlate of (cross-)protective immunity against influenza.
    Altenburg AF; Rimmelzwaan GF; de Vries RD
    Vaccine; 2015 Jan; 33(4):500-6. PubMed ID: 25498210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine.
    Skowronski DM; Janjua NZ; Sabaiduc S; De Serres G; Winter AL; Gubbay JB; Dickinson JA; Fonseca K; Charest H; Bastien N; Li Y; Kwindt TL; Mahmud SM; Van Caeseele P; Krajden M; Petric M
    J Infect Dis; 2014 Jul; 210(1):126-37. PubMed ID: 24446529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay J; Fonseca K; Charest H; Krajden M; Petric M; Mahmud SM; Van Caeseele P; Bastien N; Eshaghi A; Li Y
    J Infect Dis; 2015 Sep; 212(5):726-39. PubMed ID: 25784728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus.
    Tu W; Mao H; Zheng J; Liu Y; Chiu SS; Qin G; Chan PL; Lam KT; Guan J; Zhang L; Guan Y; Yuen KY; Peiris JS; Lau YL
    J Virol; 2010 Jul; 84(13):6527-35. PubMed ID: 20410263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Recognition of Influenza A Viruses by M158-66 Epitope-Specific CD8+ T Cells Is Determined by Extraepitopic Amino Acid Residues.
    van de Sandt CE; Kreijtz JH; Geelhoed-Mieras MM; Nieuwkoop NJ; Spronken MI; van de Vijver DA; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
    J Virol; 2016 Jan; 90(2):1009-22. PubMed ID: 26537686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human CD8
    Koutsakos M; Illing PT; Nguyen THO; Mifsud NA; Crawford JC; Rizzetto S; Eltahla AA; Clemens EB; Sant S; Chua BY; Wong CY; Allen EK; Teng D; Dash P; Boyd DF; Grzelak L; Zeng W; Hurt AC; Barr I; Rockman S; Jackson DC; Kotsimbos TC; Cheng AC; Richards M; Westall GP; Loudovaris T; Mannering SI; Elliott M; Tangye SG; Wakim LM; Rossjohn J; Vijaykrishna D; Luciani F; Thomas PG; Gras S; Purcell AW; Kedzierska K
    Nat Immunol; 2019 May; 20(5):613-625. PubMed ID: 30778243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretory IgA antibodies provide cross-protection against infection with different strains of influenza B virus.
    Asahi-Ozaki Y; Yoshikawa T; Iwakura Y; Suzuki Y; Tamura S; Kurata T; Sata T
    J Med Virol; 2004 Oct; 74(2):328-35. PubMed ID: 15332283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three Types of Broadly Reacting Antibodies against Influenza B Viruses Induced by Vaccination with Seasonal Influenza Viruses.
    Hirano D; Ohshima N; Kubota-Koketsu R; Yamasaki A; Kurosawa G; Okuno Y; Yoshida S; Kurosawa Y
    J Immunol Res; 2018; 2018():7251793. PubMed ID: 29854845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic and genomic characterization of human influenza A and B viruses circulating in Argentina after the introduction of influenza A(H1N1)pdm09.
    Russo ML; Pontoriero AV; Benedetti E; Czech A; Avaro M; Periolo N; Campos AM; Savy VL; Baumeister EG
    J Med Microbiol; 2014 Dec; 63(Pt 12):1626-1637. PubMed ID: 25351708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine-mismatched influenza B/Yamagata lineage viruses in Cuba, 2012-2013 season.
    Arencibia A; Piñón A; Acosta B; Fernandez L; Muné M; Valdés O; Savón C; Oropesa S; Gonzalez G; Roque R; Gonzalez G; Hernández B; Alfonso JM
    Infect Genet Evol; 2018 Mar; 58():110-114. PubMed ID: 29229320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A CTL-based liposomal vaccine capable of inducing protection against heterosubtypic influenza viruses in HLA-A*0201 transgenic mice.
    Matsui M; Kohyama S; Suda T; Yokoyama S; Mori M; Kobayashi A; Taneichi M; Uchida T
    Biochem Biophys Res Commun; 2010 Jan; 391(3):1494-9. PubMed ID: 20060099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolutionary pattern of reemerging influenza B/Victoria lineage viruses in São Paulo, Brazil, 1996-2012: Implications for vaccine composition strategy.
    Paiva TM; Benega MA; Silva DB; Santos KC; Cruz AS; Hortenci MF; Barbieri MT; Monteiro MM; Barbosa HA; Carvalhanas TR
    J Med Virol; 2013 Nov; 85(11):1983-9. PubMed ID: 23926069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic analysis and evaluation of the reassortment of influenza B viruses isolated in Taiwan during the 2004-2005 and 2006-2007 epidemics.
    Jian JW; Lai CT; Kuo CY; Kuo SH; Hsu LC; Chen PJ; Wu HS; Liu MT
    Virus Res; 2008 Feb; 131(2):243-9. PubMed ID: 17996973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.